Menu
Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. The company invents unique, market-changing solutions that are designed to deliver radiation treatments for even the most complex cases-while making commonly treatable cases even easier-to meet the full spectrum of patient needs. Accuray is dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as they partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Sunnyvale, California, with facilities worldwide.
1310 Chesapeake Ter
Sunnyvale, California 94089
Phone: 14087164600
www.accuray.com
In Thursday’s session, Accuray Incorporated (NASDAQ:ARAY) marked $2.82 per share, down from $2.95 in the previous session. While Accuray Incorporated has underperformed by -4.41%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ARAY fell by -15.32%, with highs and lows ranging from $3.67 to $1.70, whereas […]
Company to Take Part in Fireside Chat Tuesday, March 14, 2023 at 1:00pm PST / 4:00pm EST SUNNYVALE, Calif. , March 8, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the 33 rd Annual Oppenheimer Healthcare Conference taking place March 13-15, 2023.
Company to Take Part in Fireside Chat Monday , March 6, 2023 at 10:30am PST / 1:30pm EST SUNNYVALE, Calif. , Feb. 21, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the Cowen 43 rd Annual Health Care Conference taking place March 6-8, 2022 .
Accuray Incorporated (NASDAQ:ARAY) marked $3.12 per share on Wednesday, up from a previous closing price of $3.10. While Accuray Incorporated has overperformed by 0.81%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ARAY fell by -14.99%, with highs and lows ranging from $4.03 to $1.70, whereas […]
The radiation-oncology machine company saw shares rise after it released an earnings report.
Accuray''s revenue did fall YoY as reported, but the company beat expectations and product revenue reached a new all-time high with 8% YoY constant-currency growth. Read more here.
Accuray Incorporated (NASDAQ:NASDAQ:ARAY) Q2 2023 Earnings Conference Call February 1, 2023 4:30 PM ETCompany ParticipantsJesse Chew - Senior Vice President, General Counsel & Corporate…
WASHINGTON (dpa-AFX) - Below are the earnings highlights for Accuray Incorporated (ARAY):Earnings: -$1.87 million in Q2 vs. $0.18 million in the same period last year. EPS: -$0.02 in Q2 vs. $0.00 …
Accuray press release (ARAY): Q2 GAAP EPS of -$0.02 beats by $0.01.Revenue of $114.76M (-1.3% Y/Y) beats by $7.73M.Fiscal Year 2023 Financial GuidanceAccuray''s financial guidance…
Delivered strong Q2 performance amidst challenging macroenvironment; Reiterate fiscal year guidance SUNNYVALE, Calif., Feb. 1, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the second quarter of fiscal 2023 ended December 31, 2022. Second…
Accuray (NASDAQ: ARAY ) is set to give its latest quarterly earnings report on Wednesday, 2023-02-01. Here''s what investors need to know before the announcement. Analysts estimate that Accuray will report an earnings per share (EPS) of $-0.02. Accuray bulls will hope to hear the company announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next … Full story available on Benzinga.com